158 related articles for article (PubMed ID: 35394144)
1. Consolidative active scanning proton therapy for mediastinal lymphoma: selection criteria, treatment implementation and clinical feasibility.
Dionisi F; Scartoni D; Rombi B; Vennarini S; Righetto R; Farace P; Lorentini S; Schwarz M; Di Murro L; Demofonti C; D'Angelillo RM; Petrongari MG; Sanguineti G; Amichetti M
Strahlenther Onkol; 2022 Jun; 198(6):558-565. PubMed ID: 35394144
[TBL] [Abstract][Full Text] [Related]
2. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
3. Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold.
Righetto R; Fracchiolla F; Widesott L; Lorentini S; Dionisi F; Rombi B; Scartoni D; Vennarini S; Schwarz M; Farace P
Radiother Oncol; 2022 Apr; 169():43-50. PubMed ID: 35189153
[TBL] [Abstract][Full Text] [Related]
4. Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.
König L; Bougatf N; Hörner-Rieber J; Chaudhri N; Mielke T; Klüter S; Haefner MF; Rieken S; Haberer T; Debus J; Herfarth K
Strahlenther Onkol; 2019 Jul; 195(7):677-687. PubMed ID: 30972453
[TBL] [Abstract][Full Text] [Related]
5. Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness.
Tseng YD; Maes SM; Kicska G; Sponsellor P; Traneus E; Wong T; Stewart RD; Saini J
Radiat Oncol; 2019 Dec; 14(1):243. PubMed ID: 31888769
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy.
Loap P; Orlandi E; De Marzi L; Vitolo V; Barcellini A; Iannalfi A; Dendale R; Kirova Y; Mirandola A
Acta Oncol; 2022 Aug; 61(8):979-986. PubMed ID: 35668710
[TBL] [Abstract][Full Text] [Related]
7. Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
Abbassi LM; Goudjil F; Arsène-Henry A; Dendale R; Kirova YM
Cancer Radiother; 2019 Dec; 23(8):922-925. PubMed ID: 31257097
[TBL] [Abstract][Full Text] [Related]
8. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
9. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment.
Zeng C; Plastaras JP; James P; Tochner ZA; Hill-Kayser CE; Hahn SM; Both S
Acta Oncol; 2016; 55(9-10):1132-1138. PubMed ID: 27332881
[TBL] [Abstract][Full Text] [Related]
10. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
[TBL] [Abstract][Full Text] [Related]
11. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
[TBL] [Abstract][Full Text] [Related]
12. Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy.
Edvardsson A; Kügele M; Alkner S; Enmark M; Nilsson J; Kristensen I; Kjellén E; Engelholm S; Ceberg S
Acta Oncol; 2019 Jan; 58(1):95-104. PubMed ID: 30280626
[TBL] [Abstract][Full Text] [Related]
13. Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
Tseng YD; Pankuch M; Mohindra P; McGee L; Rossi C; Flampouri S; Hajj C; Molitoris JK; Chang JH; Tsai H; Stevens C; Rosen L; Vargas C; Hartsell W
Am J Clin Oncol; 2021 Jun; 44(6):269-274. PubMed ID: 33852456
[TBL] [Abstract][Full Text] [Related]
14. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
[TBL] [Abstract][Full Text] [Related]
15. Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
Ntentas G; Dedeckova K; Andrlik M; Aznar MC; George B; Kubeš J; Darby SC; Cutter DJ
Pract Radiat Oncol; 2019 May; 9(3):179-187. PubMed ID: 30708133
[TBL] [Abstract][Full Text] [Related]
16. Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
Cartechini G; Fracchiolla F; Menegotti L; Scifoni E; La Tessa C; Schwarz M; Farace P; Tommasino F
Radiat Oncol; 2020 Oct; 15(1):228. PubMed ID: 33008412
[TBL] [Abstract][Full Text] [Related]
17. A case study evaluating deep inspiration breath-hold and intensity-modulated radiotherapy to minimise long-term toxicity in a young patient with bulky mediastinal Hodgkin lymphoma.
Tomaszewski JM; Crook S; Wan K; Scott L; Foroudi F
J Med Radiat Sci; 2017 Mar; 64(1):69-75. PubMed ID: 28188697
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
Gorgisyan J; Munck Af Rosenschold P; Perrin R; Persson GF; Josipovic M; Belosi MF; Engelholm SA; Weber DC; Lomax AJ
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1121-1128. PubMed ID: 28964587
[TBL] [Abstract][Full Text] [Related]
20. Pencil beam scanning proton therapy for mediastinal lymphomas in deep inspiration breath-hold: a retrospective assessment of plan robustness.
Hörberger F; Andersson KM; Enmark M; Kristensen I; Flejmer A; Edvardsson A
Acta Oncol; 2024 Feb; 63():62-69. PubMed ID: 38415848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
